Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas Kipps

Distinguished Professor

University of California, San Diego

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

John G. Gribben

Professor

Queen Mary University of London

UNITED KINGDOM

View details

Jordan Gauthier

Associate Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Constantine S. Tam

AUSTRALIA

View details

John C. Byrd

UPMC Hillman Cancer Center

UNITED STATES

View details

Nicholas Chiorazzi

Professor and Center Head

Feinstein Institute for Medical Research

UNITED STATES

View details

Paolo Ghia

ITALY

View details

Paul M. Barr

University of Rochester

UNITED STATES

View details

Deborah Stephens

Assistant Professor

Huntsman Cancer Institute

UNITED STATES

View details

Tanya Siddiqi

Associate Professor

City Of Hope National Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Kipps

Research Interests

Explore related searches

Articles (12)

Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004

Unfinished business in chronic lymphocytic leukemia: translational and clinical priorities for a cure

Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis

Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study

A scholar of blood and beauty: remembering Prof. Jacques-Louis Binet (1932–2024)

Wnt5a induces ROR1 dependent NF-κB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia

Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia

Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein

Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

Challenging the Value of Minimal Residual Disease in Predicting Outcome of Patients With Chronic Lymphocytic Leukemia

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study

Collaborators (9)

John G. Gribben

Jordan Gauthier

Constantine S. Tam

John C. Byrd

Nicholas Chiorazzi

Paolo Ghia

Paul M. Barr

Deborah Stephens

Tanya Siddiqi

Make your next move.